KRAS mutant lung cancer: progress thus far on an elusive therapeutic target

Overview

cited authors

Bhattacharya, Saveri; Socinski, Mark A.; Burns, Timothy F.

authors

Socinski, Mark A., MD

Publication Date

January 1, 2015

webpage

Web of Science

published in

CLINICAL AND TRANSLATIONAL MEDICINE Journal

Research

keywords

KRAS mutant NSCLC
MAPK pathway
Targeted therapy

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.